[go: up one dir, main page]

NO20004872L - FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant - Google Patents

FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant

Info

Publication number
NO20004872L
NO20004872L NO20004872A NO20004872A NO20004872L NO 20004872 L NO20004872 L NO 20004872L NO 20004872 A NO20004872 A NO 20004872A NO 20004872 A NO20004872 A NO 20004872A NO 20004872 L NO20004872 L NO 20004872L
Authority
NO
Norway
Prior art keywords
antioxidant
pharmaceutical compositions
special use
stabilizing pharmaceutical
stabilizing
Prior art date
Application number
NO20004872A
Other languages
English (en)
Other versions
NO332004B1 (no
NO20004872D0 (no
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20004872D0 publication Critical patent/NO20004872D0/no
Publication of NO20004872L publication Critical patent/NO20004872L/no
Publication of NO332004B1 publication Critical patent/NO332004B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20004872A 1998-04-02 2000-09-28 Fremgangsmate for a stabilisere en vandig farmasoytisk sammensetning, anvendelse av en antioksidant for a oppna nevnte stabilisering, samt en vandig oyensammensetning NO332004B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98106046 1998-04-02
PCT/EP1999/002221 WO1999051230A1 (en) 1998-04-02 1999-03-31 Method for stabilizing pharmaceutical compositions by special use of an antioxidant

Publications (3)

Publication Number Publication Date
NO20004872D0 NO20004872D0 (no) 2000-09-28
NO20004872L true NO20004872L (no) 2000-11-09
NO332004B1 NO332004B1 (no) 2012-05-21

Family

ID=8231706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004872A NO332004B1 (no) 1998-04-02 2000-09-28 Fremgangsmate for a stabilisere en vandig farmasoytisk sammensetning, anvendelse av en antioksidant for a oppna nevnte stabilisering, samt en vandig oyensammensetning

Country Status (21)

Country Link
US (2) US6576649B1 (no)
EP (1) EP1098649B1 (no)
JP (1) JP2002510627A (no)
KR (1) KR100617430B1 (no)
CN (1) CN1138542C (no)
AT (1) ATE269079T1 (no)
AU (1) AU756000B2 (no)
BR (1) BR9909329A (no)
CA (1) CA2326137C (no)
CZ (1) CZ301851B6 (no)
DE (1) DE69918122T2 (no)
DK (1) DK1098649T3 (no)
ES (1) ES2224651T3 (no)
HU (1) HU226588B1 (no)
ID (1) ID26033A (no)
IL (2) IL138476A0 (no)
NO (1) NO332004B1 (no)
NZ (1) NZ507026A (no)
PL (1) PL194914B1 (no)
WO (1) WO1999051230A1 (no)
ZA (1) ZA200005098B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
CA2393718A1 (en) * 1999-12-21 2001-06-28 Dsm N.V. Preserving active fungicide in an aqueous solution
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
KR100355892B1 (ko) * 2000-01-06 2002-10-12 주식회사 코리아나화장품 레티놀과 테트라디부틸 펜타에리스리틸히드록시히드로신나메이트를 함유하는 화장료 조성물
JP4822609B2 (ja) * 2000-05-22 2011-11-24 クラレメディカル株式会社 抗菌性組成物
US20030064102A1 (en) * 2000-05-22 2003-04-03 Kazumitsu Nakatsuka Antimicrobial Composition
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
AU2001278779A1 (en) * 2000-08-25 2002-03-04 Senju Pharmaceutical Co. Ltd. Aqueous suspension preparations
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
WO2004064781A2 (en) * 2003-01-14 2004-08-05 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
CN1737047B (zh) * 2004-08-19 2010-05-05 住友化学株式会社 含填充材料的聚烯烃树脂组合物及其成形品
US20060148899A1 (en) * 2004-10-25 2006-07-06 Green Kenneth E Ophthalmic compositions and methods of using the same
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
KR101454674B1 (ko) 2006-03-17 2014-10-27 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
WO2008008636A2 (en) * 2006-07-10 2008-01-17 Johnson & Johnson Vision Care, Inc. Packages for ophthalmic lenses containing pharmaceutical agents
WO2008042454A1 (en) * 2006-09-29 2008-04-10 Johnson & Johnson Vision Care, Inc. Methods and ophthalmic devices used in the treatment of ocular allergies
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
US8986728B2 (en) * 2008-05-30 2015-03-24 Abbott Cardiovascular Systems Inc. Soluble implantable device comprising polyelectrolyte with hydrophobic counterions
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
WO2009157586A1 (ja) * 2008-06-27 2009-12-30 祐徳薬品工業株式会社 フェンタニルまたはその塩含有経皮吸収型貼付剤
KR20100023538A (ko) * 2008-08-22 2010-03-04 삼성전자주식회사 고상 시약의 제조방법 및 고상 시약을 수용하는 미세유동장치
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
US8765787B2 (en) * 2008-11-21 2014-07-01 Bridge Pharma, Inc. Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
KR101013102B1 (ko) * 2008-12-08 2011-02-14 주식회사 케이에스비 토너 카트리지의 블레이드 용접 장치
JP5675183B2 (ja) * 2009-06-16 2015-02-25 ロート製薬株式会社 水性組成物
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
WO2017078953A1 (en) * 2015-11-06 2017-05-11 Accuitis Pharmaceuticals, Inc. Use of proteasome inhibitors to treat ocular disorders
CN114262476B (zh) * 2021-12-30 2023-09-05 沈阳兴齐眼药股份有限公司 提高妥布霉素滴眼液稳定性的包装容器
CN114262477B (zh) * 2021-12-30 2023-09-19 沈阳兴齐眼药股份有限公司 抑制妥布霉素滴眼液变色的包装容器及其制备方法
CN114441691B (zh) * 2022-04-12 2022-08-23 广州国标检验检测有限公司 一种眼用制剂容器中塑料添加剂的检测方法
CA3264067A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS-REDUCING AGENT
WO2024028815A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising an anti-allergen and a redness reduction agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
FR2231377B1 (no) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
JP3666884B2 (ja) * 1992-05-21 2005-06-29 日本ゼオン株式会社 医療用器材
JP3098895B2 (ja) * 1993-06-28 2000-10-16 三菱化学株式会社 液体用容器
JP3021312B2 (ja) * 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
JP3055753B2 (ja) * 1994-07-05 2000-06-26 昭和薬品化工株式会社 フマル酸ケトチフェン含有点眼液
JP3693696B2 (ja) * 1994-12-15 2005-09-07 久光製薬株式会社 ケトチフェン含有経皮投与製剤
DE69606713T2 (de) * 1995-08-29 2000-08-03 Exxon Chemical Patents, Inc. Strahlungsbeständiges polypropylen und daraus herstellbare gegenstände
KR100228514B1 (ko) * 1996-09-05 1999-11-01 한승수 비스테로이드성 소염진통제를 활성성분으로 하는 경피흡수제제의 제조방법

Also Published As

Publication number Publication date
PL343156A1 (en) 2001-07-30
DE69918122T2 (de) 2005-06-16
BR9909329A (pt) 2000-12-12
ATE269079T1 (de) 2004-07-15
AU756000B2 (en) 2003-01-02
US20020103196A1 (en) 2002-08-01
HUP0101582A3 (en) 2002-10-28
IL138476A (en) 2006-04-10
PL194914B1 (pl) 2007-07-31
US6576649B1 (en) 2003-06-10
ZA200005098B (en) 2001-05-21
KR20010042361A (ko) 2001-05-25
US6455547B1 (en) 2002-09-24
ES2224651T3 (es) 2005-03-01
HUP0101582A2 (hu) 2002-03-28
NZ507026A (en) 2003-09-26
NO332004B1 (no) 2012-05-21
DK1098649T3 (da) 2004-10-04
CN1138542C (zh) 2004-02-18
CZ20003579A3 (cs) 2001-01-17
KR100617430B1 (ko) 2006-08-31
HU226588B1 (en) 2009-04-28
IL138476A0 (en) 2001-10-31
AU3811999A (en) 1999-10-25
CZ301851B6 (cs) 2010-07-07
EP1098649A1 (en) 2001-05-16
NO20004872D0 (no) 2000-09-28
DE69918122D1 (de) 2004-07-22
WO1999051230A1 (en) 1999-10-14
CN1295474A (zh) 2001-05-16
JP2002510627A (ja) 2002-04-09
CA2326137C (en) 2009-06-02
EP1098649B1 (en) 2004-06-16
ID26033A (id) 2000-11-16
CA2326137A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
NO20004872L (no) FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant
DE69737592D1 (de) Mittel gegen juckreiz
IL125735A (en) Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound
NO20034056D0 (no) Proliferative sykdommer
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
BG104780A (en) Inhibitors of phospholipase enzymes
WO2002030353A3 (en) NF-λB INHIBITORS
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
DE60214359D1 (en) Stickstoffbasierte camptothecin-derivate
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
DK0956859T3 (da) Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf
WO2005007123A3 (en) Pin1-modulating compounds and methods of use thereof
PT1282418E (pt) Utilizacao de derivados pirazolo para o tratamento da infertilidade
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
EA200000522A1 (ru) 5-htагонисты
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
WO2002026730A3 (en) Fluorinated quinolones as antimitotic and antitumor agents
EP1436279B8 (en) Chemical compounds
PT1144348E (pt) Inibidores de lta, hidrolase
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
WO2004009027A3 (en) Method and composition for treating and preventing herpesvirus infection

Legal Events

Date Code Title Description
MK1K Patent expired